|Bid||0.00 x 1200|
|Ask||0.00 x 800|
|Day's Range||27.51 - 28.95|
|52 Week Range||10.69 - 34.49|
|Beta (5Y Monthly)||1.81|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.00|
DraftKings (DKNG) closed the most recent trading day at $29.04, moving -1.36% from the previous trading session.
Key Insights Given the large stake in the stock by institutions, DraftKings' stock price might be vulnerable to their...
My three top picks are CRISPR Therapeutics (NASDAQ: CRSP), DraftKings (NASDAQ: DKNG), and Roivant Sciences (NASDAQ: ROIV). Here's why these three incredible growth stocks are no-brainer buys in October and beyond. CRISPR Therapeutics and its partner Vertex Pharmaceuticals are poised to make history in the fourth quarter of 2023.